Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement

Six Awards Foster Patient-Driven Parkinson’s Research

New York, NY and Miami, FL — The Parkinson’s Foundation is pleased to announce $60,000 in funding for six innovative patient-centered research projects.  The awards, the first of their kind in the Parkinson's community, support patient-scientist teams in their efforts to develop innovative models of patient engagement.  The projects are supported through the Parkinson’s Advocates in Research (PAIR) Leadership Awards.

“As a leader in the patient engagement space, we are proud to support researcher-patient teams who are developing innovative ways of working together,” said John L. Lehr, chief executive officer of the Parkinson’s Foundation.  “It is more critical than ever that we guide research to better meet the needs of our community, and including patient voices is key.”

PAIR Leadership Awards are an extension of Parkinson’s Advocates in Research, a pioneering program established by the Foundation to advance researcher-patient collaborations.  They reflect the foundation’s commitment to targeting research to meet patient needs by building collaborations between scientists and people who live with Parkinson’s disease (PD).  Awards are available for up to $10,000 for patient-centered research projects. 

Among this year’s awardees is a team from Emory University School of Medicine, a Parkinson’s Foundation Center of Excellence: Madeleine Hackney, PhD, and Ron Wincek, a foundation research advocate who lives with Parkinson’s. Their project, “The DREAMS Team: Galvanizing Research Participation in the Parkinson’s Disease Underserved Community,” aims to train underserved older adults in the PD community to serve as advisers on study teams and to aid recruitment efforts of underserved participants with PD by local clinical trials.

“Over the years, our team has found that patients have valuable and often surprising insights that can improve our work in research, care and support,” said Dr. Hackney. “I applaud the Parkinson's Foundation for investing in our efforts to encourage research participation in underserved communities.”

2017 PAIR Leadership Awards:

  1. Development of a Virtual Case Manager for People with Parkinson’s Disease
    Bastiaan R. Bloem, M.D., Ph.D., Radboud University Nijmegen Medical Centre, Parkinson’s Foundation Center of Excellence, Netherlands
    John Andrejack, Parkinson’s Foundation Research Advocate
  2. Optimizing Mindfulness Based Stress Reduction Program for Accessibility, Feasibility, Comfort, and Effectiveness for People with PD
    Michelle Burack, M.D., Ph.D., and Dan Kinel, University of Rochester Medical Center, Parkinson’s Foundation Center of Excellence
  3. PAIRing up to Address Neuropsychiatric Concerns in Parkinson's Disease
    Jennifer Goldman, M.S., M.Phil., Rush University Medical Center, Parkinson’s Foundation Center of Excellence
    Don Simmonds, Parkinson’s Foundation Research Advocate
  4. The DREAMS Team: Galvanizing Research Participation in the Parkinson’s Underserved Community
    Madeleine Hackney, Ph.D., Molly Perkins, Ph.D., Rebeca Dillard and Ron Wincek, Emory University School of Medicine, Parkinson’s Foundation Center of Excellence
  5. An Investigation of Tracking Technology in the Setting of an Established Exercise Program for Individuals with Parkinson Disease
    Sarah Ingersoll, M.B.A., and Kris Mendenhall, University of Southern California Keck School of Medicine
  6. Assessment of Changes in Gait Patterns during Cognitive and Visual Dual-Tasking using the Xbox Kinect System
    Joe Signorile, Roberto Chen, University of Miami, Parkinson’s Foundation Center of Excellence

About the Parkinson's Foundation
The Parkinson's Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience, and passion of our global Parkinson’s community.  For more information, visit www.parkinson.org or call 1-800-4PD-INFO (473-4636).

About Parkinson's Disease (PD)
Affecting nearly one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer's and is the 14th-leading cause of death in the United States.  It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety).  There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the United States alone.

Wednesday, November 29, 2017
The National Parkinson Foundation Awards Four Innovative Research Grants
Wednesday, November 4, 2015

One Million Dollar Investment in Clinical Research in Parkinson’s Disease

MIAMI — The National Parkinson Foundation (NPF) announced today that it has funded four new grants in Parkinson’s disease (PD) research. The four grants target key scientific questions about gender differences in Parkinson’s, cognition and inflammation.

Should Patients and Families Be Considering Tasigna (Nilotinib) Therapy for Parkinson’s Disease? The NPF Recommends Further Study but Not Clinical Use of this Investigational Drug
Wednesday, October 21, 2015

Tasigna (Nilotinib) is a leukemia drug that has recently been tested for safety in a small, phase I clinical trial on about a dozen Parkinson’s disease patients. The study had positive results that certainly warrant the continuation to a phase II trial, however it is too early for patients to seek treatment outside the setting of a clinical trial. The study was very small, and it was not placebo controlled.

NatGeo to Air Live Parkinson's DBS Surgery: What Should You Know?
Tuesday, October 20, 2015

The Parkinson’s Disease Foundation (PDF) has learned that later this week, the National Geographic Channel will air a live television broadcast of deep brain stimulation surgery for Parkinson’s disease (PD).

Parkinson's Disease Foundation and American Parkinson Disease Association Collaborate to Cultivate Future Parkinson's Scientific Leaders
Thursday, October 15, 2015

The Parkinson's Disease Foundation® (PDF®) and the American Parkinson Disease Association (APDA) are pleased to announce their collaboration on Summer Student Fellowships to support research that will help solve, treat and end Parkinson's disease.

PDF Research Advocates Highlight Unmet Needs in Parkinson’s at FDA Meeting
Tuesday, September 29, 2015

The Parkinson’s Disease Foundation (PDF) is pleased to report that five of its Research Advocates represented the community at last week’s Food and Drug Administration’s (FDA) Patient-Focused Drug Development meeting on Parkinson’s Disease in Silver Spring, MD.

National Parkinson Foundation Ohio Chapter Now Serves Entire State
Monday, September 21, 2015

Moving Day® Cleveland, A Walk for Parkinson’s, Slated for June 2016

Columbus — The National Parkinson Foundation (NPF) Central & Southeast Ohio Chapter has officially changed its name to National Parkinson Foundation Ohio. The name change signifies the expansion of service statewide to the approximately 30-50,000 Ohioans with Parkinson’s disease (PD). 

Parkinson's Disease Foundation Mobilizes Community to Address Unmet Needs of Women Living with Parkinson’s
Wednesday, September 16, 2015

The Parkinson's Disease Foundation® (PDF®) is pleased to launch its Women and PD Initiative, the first national coordinated effort dedicated to improving the health and well-being of women living with Parkinson’s disease. The initiative launches this week with a three-day conference in Florham Park, NJ.

Parkinson's Disease Foundation Highlights Under-recognized Aspects of Disease with New Online Educational Series
Tuesday, September 15, 2015

The Parkinson's Disease Foundation® (PDF®) is pleased to announce the launch of its latest series of PD ExpertBriefings — six free online seminars designed to shed light on under-recognized aspects of Parkinson's disease. The series, presented by leaders in Parkinson's research and care, begins today, Tuesday, September 15 at 1:00 PM ET.

PDF-Funded Research Paves the Way to Phase III Drug Trial
Wednesday, September 2, 2015

The Parkinson’s Disease Foundation (PDF) is pleased to announce that research initially launched with PDF funding will be tested in a phase III clinical trial opening in 2016. The study, which two of PDF’s volunteer Research Advocates are helping to oversee, is assessing the potential of the nutritional supplement inosine for the treatment of Parkinson’s disease.

The National Parkinson Foundation’s Medical Director Publishes New Book on Breakthrough Therapies for Parkinson’s Disease
Monday, August 31, 2015

Sequel to 2013 Bestseller, “Parkinson’s Treatment: 10 Secrets to a Happier Life”

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.